Effect of preventive hormonal therapy on breast density: A systematic qualitative review

Scientific World Journal

Volumn 2014, Issue , 2014, Pages

  Lienart, Virginie ^a   Carly, Birgit ^a   Kang, Xin ^a   Guzy, Laura ^a   Sajovitz, Anna Maria ^a   Liebens, Fabienne ^a  

^a SAINT PIERRE UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATASE INHIBITOR; RALOXIFENE; TAMOXIFEN; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS;

BREAST; BREAST BIOPSY; BREAST CANCER; BREAST DENSITY; BREAST DISEASE; CANCER RADIOTHERAPY; CANCER RISK; CANCER SURGERY; DENSITY; FAMILY HISTORY; FEMALE; HORMONAL THERAPY; HUMAN; MAMMOGRAPHY; MEDICATION COMPLIANCE; MENOPAUSE; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOPENIA; OSTEOPOROSIS; QUALITATIVE RESEARCH; REVIEW; SYSTEMATIC REVIEW; TREATMENT DURATION; TUMOR BIOPSY; BREAST NEOPLASMS;

ANTINEOPLASTIC AGENTS, HORMONAL; AROMATASE INHIBITORS; BREAST NEOPLASMS; HUMANS; RALOXIFENE; TAMOXIFEN;

EID: 84901258132     PISSN: 23566140     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1155/2014/942386     Document Type: Review

References (89)

1. Wolfe J. N., Breast patterns as an index of risk for developing breast cancer. American Journal of Roentgenology 1976 126 6 1130 1139 2-s2.0-0017067087
2. Boyd N. F., Guo H., Martin L. J., Sun L., Stone J., Fishell E., Jong R. A., Hislop G., Chiarelli A., Minkin S., Yaffe M. J., Mammographic density and the risk and detection of breast cancer. New England Journal of Medicine 2007 356 3 227 236 2-s2.0-33846407655 10.1056/NEJMoa062790 (Pubitemid 46143226)
3. Boyd N. F., Martin L. J., Yaffe M. J., Minkin S., Mammographic density and breast cancer risk: current understanding and future prospects. Breast Cancer Research 2011 13 6 223 2-s2.0-80755173295 10.1186/bcr2942
4. Santen R. J., Boyd N. F., Chlebowski R. T., Cummings S., Cuzick J., Dowsett M., Easton D., Forbes J. F., Key T., Hankinson S. E., Howell A., Ingle J., Critical assessment of new risk factors for breast cancer: considerations for development of an improved risk prediction model. Endocrine-Related Cancer 2007 14 2 169 187 2-s2.0-34547797981 10.1677/ERC-06-0045 (Pubitemid 47242621)
5. McCormack V. A., Dos Santos Silva I., Breast density and parenchymal patterns as markers of breast cancer risk: a meta-analysis. Cancer Epidemiology Biomarkers and Prevention 2006 15 6 1159 1169 2-s2.0-33745683831 10.1158/1055-9965.EPI-06-0034
6. Vachon C. M., Kuni C. C., Anderson K., Anderson V. E., Sellers T. A., Association of mammographically defined percent breast density with epidemiologic risk factors for breast cancer (United States). Cancer Causes and Control 2000 11 7 653 662 2-s2.0-0033869841 10.1023/A:1008926607428 (Pubitemid 30636365)
7. Martin L. J., Boyd N. F., Mammographic density. Potential mechanisms of breast cancer risk associated with mammographic density: hypotheses based on epidemiological evidence. Breast Cancer Research 2008 10 1 201 2-s2.0-43149112727 10.1186/bcr1831
8. Boyd N. F., Lockwood G. A., Martin L. J., Byng J. W., Yaffe M. J., Tritchler D. L., Mammographic density as a marker of susceptibility to breast cancer: a hypothesis. IARC Scientific Publications 2001 154 163 169 2-s2.0-0035229811
9. Maskarinec G., Pagano I., Lurie G., Kolonel L. N., A longitudinal investigation of mammographic density: the multiethnic cohort. Cancer Epidemiology Biomarkers and Prevention 2006 15 4 732 739 2-s2.0-33646263128 10.1158/1055-9965.EPI-05-0798
10. Assi V., Warwick J., Cuzick J., Duffy S. W., Clinical and epidemiological issues in mammographic density. Nature Reviews Clinical Oncology 2012 9 1 33 40 2-s2.0-84655176502 10.1038/nrclinonc.2011.173
11. Boyd N. F., Martin L. J., Bronskill M., Yaffe M. J., Duric N., Minkin S., Breast tissue composition and susceptibility to breast cancer. Journal of the National Cancer Institute 2010 102 16 1224 1237 2-s2.0-77955933965 10.1093/jnci/djq239
12. American College of Radiology, American College of Radiology Breast Imaging Reporting and Data System (BI-RADS) 2003 4th Reston, Va, USA American College of Radiology
13. Boyd N. F., Tamoxifen, mammographic density, and breast cancer prevention. Journal of the National Cancer Institute 2011 103 9 704 705 2-s2.0-79955756153 10.1093/jnci/djr115
14. Kerlikowske K., Cook A. J., Buist D. S. M., Cummings S. R., Vachon C., Vacek P., Miglioretti D. L., Breast cancer risk by breast density, menopause, and postmenopausal hormone therapy use. Journal of Clinical Oncology 2010 28 24 3830 3837 2-s2.0-77956252973 10.1200/JCO.2009.26.4770
15. Cuzick J., DeCensi A., Arun B., Brown P. H., Castiglione M., Dunn B., Forbes J. F., Glaus A., Howell A., von Minckwitz G., Vogel V., Zwierzina H., Preventive therapy for breast cancer: a consensus statement. The Lancet Oncology 2011 12 5 496 503 2-s2.0-79955479172 10.1016/S1470-2045(11)70030-4
16. Goss P. E., Ingle J. N., Martino S., Robert N. J., Muss H. B., Piccart M. J., Castiglione M., Tu D., Shepherd L. E., Pritchard K. I., Livingston R. B., Davidson N. E., Norton L., Perez E. A., Abrams J. S., Cameron D. A., Palmer M. J., Pater J. L., Randomized trial of letrozole following tamoxifen as extended adjuvant therapy in receptor-positive breast cancer: updated findings from NCIC CTG MA.17. Journal of the National Cancer Institute 2005 97 17 1262 1271 2-s2.0-24744450378 10.1093/jnci/dji250 (Pubitemid 41535367)
17. Arimidex, Tamoxifen, Alone or in Combination (ATAC) Trialists' Group, Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trial. The Lancet Oncology 2008 9 1 45 53 10.1016/S1470-2045(07)70385-6
18. Chen J. H., Nie K., Bahri S., Hsu C., Hsu F., Shih H., Lin M., Nalcioglu O., Su M., Decrease in breast density in the contralateral normal breast of patients receiving neoadjuvant chemotherapy: MR imaging evaluation. Radiology 2010 255 1 44 52 2-s2.0-77950452352 10.1148/radiol.09091090
19. Dershaw D. D., Shank B., Reisinger S., Mammographic findings after breast cancer treatment with local excision and definitive irradiation. Radiology 1987 164 2 455 461 2-s2.0-0023262004 (Pubitemid 17097966)
20. Margolin F. R., Denny S. R., Gelfand C. A., Jacobs R. P., Mammographic changes after hormone replacement therapy in patients who have undergone breast irradiation. American Journal of Roentgenology 1999 172 1 147 150 2-s2.0-0032959125 (Pubitemid 29028447)
21. Moher D., Liberati A., Tetzlaff J., Altman D. G., PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Annals of Internal Medicine 2009 151 4 264 269 10.7326/0003-4819-151-4- 200908180-00135
22. Meade M. O., Richardson W. S., Selecting and appraising studies for a systematic review. Annals of Internal Medicine 1997 127 7 531 537 2-s2.0-0347453077 (Pubitemid 27419445)
23. Counsell C., Formulating questions and locating primary studies for inclusion in systematic reviews. Annals of Internal Medicine 1997 127 5 380 387 2-s2.0-0030854892 (Pubitemid 27362747)
24. Ursin G., Pike M. C., Spicer D. V., Porrath S. A., Reitherman R. W., Can mammographic densities predict effects of tamoxifen on the breast? Journal of the National Cancer Institute 1996 88 2 128 129 2-s2.0-0030028822 (Pubitemid 26020102)
25. Slanetz P. J., Grandpre L. E., Yeh E. D., Kopans D. B., Mendel J. B., Effect of tamoxifen on breast tissue density in premenopausal breast cancer. Breast Journal 2004 10 1 27 32 2-s2.0-0742288165 10.1111/j.1524-4741.2004.09606. x (Pubitemid 38146376)
26. Taylor C., Georgian-Smith D., Regression of breast cancer in four patients treated with tamoxifen: mammographic features. American Journal of Roentgenology 1994 162 3 613 616 2-s2.0-0028212592 (Pubitemid 24093564)
27. Christodoulakos G. E., Lambrinoudaki I. V., Vourtsi A. D., Panoulis K. P., Creatsas G. C., Breast pain and mammographic density increase as a consequence of raloxifene therapy. Journal of Endocrinological Investigation 2002 25 6 564 566 2-s2.0-0035987938 (Pubitemid 34661848)
28. Tiersten A., Ng Y. Y., Pile-Spellman E., Nelsen C., Noguera-Irizarry W., Brafman R., Russo D., Troxel A., Johnson A., Relationship between mammographic breast density and tamoxifen in women with breast cancer. Breast Journal 2004 10 4 313 317 2-s2.0-3142724820 10.1111/j.1075-122X.2004.21332.x (Pubitemid 38924467)
29. Abdullah K. N., Raoof A., Raoof M., Effectiveness and safety of raloxifene in postmenopausal females. Journal of the College of Physicians and Surgeons Pakistan 2005 15 5 266 269 2-s2.0-21244475164 (Pubitemid 40883270)
30. Pearman L., Kagan R., Arsenault J., Muram D., The effects of raloxifene on mammographic breast density: a review of clinical trials. Menopause 2010 17 3 654 659 2-s2.0-77952275946 10.1097/gme.0b013e3181c29e56
31. Linares-Segovia B., Rodríguez-Osorio J. A., Storms-Salas G., Cervantes-Villarreal E., Effect of the raloxifene versus combined hormonal therapy on the mammary density. Revista médica del Instituto Mexicano del Seguro Social 2008 46 1 51 54 2-s2.0-48449089633
32. Cuzick J., Warwick J., Pinney E., Warren R. M. L., Duffy S. W., Tamoxifen and breast density in women at increased risk of breast cancer. Journal of the National Cancer Institute 2004 96 8 621 628 2-s2.0-2342571082 (Pubitemid 38584986)
33. Decensi A., Robertson C., Guerrieri-Gonzaga A., Serrano D., Cazzaniga M., Mora S., Gulisano M., Johansson H., Galimberti V., Cassano E., Moroni S. M., Formelli F., Lien E. A., Pelosi G., Johnson K. A., Bonanni B., Randomized double-blind 2 x 2 trial of low-dose tamoxifen and fenretinide for breast cancer prevention in high-risk premenopausal women. Journal of Clinical Oncology 2009 27 23 3749 3756 2-s2.0-68949092354 10.1200/JCO.2008.19.3797
34. Chow C. K., Venzon D., Jones E. C., Premkumar A., O'Shaughnessy J., Zujewski J., Effect of tamoxifen on mammographic density. Cancer Epidemiology Biomarkers and Prevention 2000 9 9 917 921 2-s2.0-0033796333
35. Brisson J., Brisson B., Cote G., Maunsell E., Berube S., Robert J., Tamoxifen and mammographic breast densities. Cancer Epidemiology Biomarkers and Prevention 2000 9 9 911 915 2-s2.0-0033805692
36. Atkinson C., Warren R., Bingham S. A., Day N. E., Mammographic patterns as a predictive biomarker of breast cancer risk: effect of tamoxifen. Cancer Epidemiology Biomarkers and Prevention 1999 8 10 863 866 2-s2.0-0032709388 (Pubitemid 29508720)
37. Hong J. S., Ki K. O., Significance of follow-up mammography in estimating the effect of tamoxifen in breast cancer patients who have undergone surgery. American Journal of Roentgenology 1999 173 4 905 909 2-s2.0-0032824545 (Pubitemid 29451282)
38. Konez O., Goyal M., Reaven R. E., Can tamoxifen cause a significant mammographic density change in breast parenchyma? Clinical Imaging 2001 25 5 303 308 2-s2.0-0034781878 10.1016/S0899-7071(01)00329-1 (Pubitemid 33010746)
39. Meggiorini M. L., Labi L., Vestri A. R., Porfiri L. M., Savelli S., De Felice C., Tamoxifen in women with breast cancer and mammographic density. European Journal of Gynaecological Oncology 2008 29 6 598 601 2-s2.0-56749083523
40. Chen J. H., Chang Y. C., Chang D., Wang Y., Nie K., Chang R., Nalcioglu O., Huang C., Su M., Reduction of breast density following tamoxifen treatment evaluated by 3-D MRI: preliminary study. Magnetic Resonance Imaging 2011 29 1 91 98 2-s2.0-78649930824 10.1016/j.mri.2010.07.009
41. Cuzick J., Warwick J., Pinney E., Duffy S. W., Cawthorn S., Howell A., Forbes J. F., Warren R. M. L., Tamoxifen-induced reduction in mammographic density and breast cancer risk reduction: a nested case-control study. Journal of the National Cancer Institute 2011 103 9 744 752 2-s2.0-79955758418 10.1093/jnci/djr079
42. Jackson V. P., San Martin J. A., Secrest R. J., McNabb M., Carranza-Lira S., Figueroa-Casas P., Erratum: Comparison of the effect of raloxifene and continuous-combined hormone therapy on mammographic breast density and breast tenderness in postmenopausal women (American Journal of Obstetrics and Gynecology (2003) 188 (389-394)). American Journal of Obstetrics and Gynecology 2003 188 6 1628 2-s2.0-0038677101 (Pubitemid 36741298)
43. Eilertsen A. L., Karssemeijer N., Skaane P., Qvigstad E., Sandset P. M., Differential impact of conventional and low-dose oral hormone therapy, tibolone and raloxifene on mammographic breast density, assessed by an automated quantitative method. International Journal of Obstetrics and Gynaecology 2008 115 6 773 779 2-s2.0-41949092234 10.1111/j.1471-0528.2008.01690.x (Pubitemid 351514578)
44. Eng-Wong J., Orzano-Birgani J., Chow C. K., Venzon D., Yao J., Galbo C. E., Zujewski J. A., Prindiville S., Effect of raloxifene on mammographic density and breast magnetic resonance imaging in premenopausal women at increased risk for breast cancer. Cancer Epidemiology Biomarkers and Prevention 2008 17 7 1696 1701 2-s2.0-53549101670 10.1158/1055-9965.EPI-07-2752
45. Freedman M., San Martin J., O'Gorman J., Eckert S., Lippman M. E., Lo S. B., Walls E. L., Zeng J., Digitized mammography: a clinical trial of postmenopausal women randomly assigned to receive raloxifene, estrogen, or placebo. Journal of the National Cancer Institute 2001 93 1 51 56 2-s2.0-0035798776 (Pubitemid 32060890)
46. Harvey J. A., Holm M. K., Ranganath R., Guse P. A., Trott E. A., Helzner E., The effects of bazedoxifene on mammographie breast density in postmenopausal women with osteoporosis. Menopause 2009 16 6 1193 1196 2-s2.0-71249138285 10.1097/gme.0b013e3181a7fb1e
47. Nielsen M., Raundahl J., Pettersen P. C., Loog M., Karemore G., Karsdal M. A., Christiansen C., Low-dose transdermal estradiol induces breast density and heterogeneity changes comparable to those of raloxifene. Menopause 2009 16 4 785 791 2-s2.0-68449095622 10.1097/GME.0b013e318199d07f
48. Lasco A., Gaudio A., Morini E., Morabito N., Nicita-Mauro C., Catalano A., Denuzzo G., Sansotta C., Xourafa A., Macrì I., Frisina N., Effect of long-term treatment with raloxifene on mammary density in postmenopausal women. Menopause 2006 13 5 787 792 2-s2.0-33748922260 10.1097/01.gme.0000233493.20712. ad (Pubitemid 44435033)
49. Christodoulakos G. E., Lambrinoudaki I. V., Vourtsi A. D., Panoulis K. P. C., Kelekis D. A., Creatsas G. C., Mammographic changes associated with raloxifene and tibolone therapy in postmenopausal women: a prospective study. Menopause 2002 9 2 110 116 2-s2.0-0036188092 (Pubitemid 34194105)
50. Cirpan T., Akercan F., Itil I. M., Gundem G., Bilgen I., Yucebilgin M. S., Does raloxifene therapy affect mammographic breast cancer screening in postmenopausal patients? European Journal of Gynaecological Oncology 2006 27 2 177 178 2-s2.0-33645972232
51. Cigler T., Tu D., Yaffe M. J., Findlay B., Verma S., Johnston D., Richardson H., Hu H., Qi S., Goss P. E., A randomized, placebo-controlled trial (NCIC CTG MAPI) examining the effects of letrozole on mammographie breast density and other end organs in postmenopausal women. Breast Cancer Research and Treatment 2010 120 2 427 435 2-s2.0-77950691631 10.1007/s10549-009-0662-0
52. Vachon C. M., Ingle J. N., Suman V. J., Scott C. G., Gottardt H., Olson J. E., Goss P. E., Pilot study of the impact of letrozole vs. placebo on breast density in women completing 5 years of tamoxifen. Breast 2007 16 2 204 210 2-s2.0-33947689213 10.1016/j.breast.2006.10.007 (Pubitemid 46499237)
53. Smith J., Dilawari A., Ursin G., Andreopoulou E., Checka C., Axelrod D., Guth A., Toth H., Utate M., Carapetyan K., Reich E., Diflo T., Muggia F., A pilot study of letrozole for one year in women at enhanced risk of developing breast cancer: effects on mammographic density. Anticancer Research 2012 32 4 1327 1331 2-s2.0-84859982629
54. Fabian C. J., Kimler B. F., Zalles C. M., Khan Q. J., Mayo M. S., Phillips T. A., Simonsen M., Metheny T., Petroff B. K., Reduction in proliferation with six months of letrozole in women on hormone replacement therapy. Breast Cancer Research and Treatment 2007 106 1 75 84 2-s2.0-34848911692 10.1007/s10549-006-9476-5 (Pubitemid 47498093)
55. Mousa N. A., Crystal P., Wolfman W. L., Bedaiwy M. A., Casper R. F., Aromatase inhibitors and mammographic breast density in postmenopausal women receiving hormone therapy. Menopause 2008 15 5 875 884 2-s2.0-58249085105 10.1097/gme.0b013e31816956c3
56. Prowell T. M., Blackford A. L., Byrne C., Khouri N. F., Dowsett M., Folkerd E., Tarpinian K. S., Powers P. P., Wright L. A., Donehower M. G., Jeter S. C., Armstrong D. K., Emens L. A., Fetting J. H., Wolff A. C., Garrett-Mayer E., Skaar T. C., Davidson N. E., Stearns V., Changes in breast density and circulating estrogens in postmenopausal women receiving adjuvant anastrozole. Cancer Prevention Research 2011 4 12 1993 2001 2-s2.0-83055174670 10.1158/1940-6207.CAPR-11-0154
57. Cigler T., Richardson H., Yaffe M. J., Fabian C. J., Johnston D., Ingle J. N., Nassif E., Brunner R. L., Wood M. E., Pater J. L., Hu H., Qi S., Tu D., Goss P. E., A randomized, placebo-controlled trial (NCIC CTG MAP.2) examining the effects of exemestane on mammographic breast density, bone density, markers of bone metabolism and serum lipid levels in postmenopausal women. Breast Cancer Research and Treatment 2011 126 2 453 461 2-s2.0-79958739573 10.1007/s10549-010-1322-0
58. Vachon C. M., Pankratz V. S., Scott C. G., Maloney S. D., Ghosh K., Brandt K. R., Milanese T., Carston M. J., Sellers T. A., Longitudinal trends in mammographic percent density and breast cancer risk. Cancer Epidemiology Biomarkers and Prevention 2007 16 5 921 928 2-s2.0-34250366942 10.1158/1055-9965.EPI-06-1047 (Pubitemid 46910093)
59. Boyd N. F., Dite G. S., Stone J., Gunasekara A., English D. R., McCredie M. R. E., Giles G. G., Tritchler D., Chiarelli A., Yaffe M. J., Hopper J. L., Heritability of mammographic density, a risk factor for breast cancer. New England Journal of Medicine 2002 347 12 886 894 2-s2.0-0037136543 10.1056/NEJMoa013390
60. Vachon C. M., van Gils C. H., Sellers T. A., Ghosh K., Pruthi S., Brandt K. R., Pankratz V. S., Mammographic density, breast cancer risk and risk prediction. Breast Cancer Research 2007 9 6 217 2-s2.0-40349102022 10.1186/bcr1829
61. Boyd N. F., Byng J. W., Jong R. A., Fishell E. K., Little L. E., Miller A. B., Lockwood G. A., Tritchler D. L., Yaffe M. J., Quantitative classification of mammographic densities and breast cancer risk: results from the Canadian National Breast Screening Study. Journal of the National Cancer Institute 1995 87 9 670 675 2-s2.0-0028939039
62. Martin K. E., Helvie M. A., Zhou C., Roubidoux M. A., Bailey J. E., Paramagul C., Blane C. E., Klein K. A., Sonnad S. S., Chan H., Mammographic density measured with quantitative computer-aided method: comparison with radiologists' estimates and BI-RADS categories. Radiology 2006 240 3 656 665 2-s2.0-33747601877 10.1148/radiol.2402041947 (Pubitemid 44267320)
63. van Engeland S., Snoeren P. R., Huisman H., Boetes C., Karssemeijer N., Volumetric breast density estimation from full-field digital mammograms. IEEE Transactions on Medical Imaging 2006 25 3 273 282 2-s2.0-33644610993 10.1109/TMI.2005.862741 (Pubitemid 43320644)
64. Nie K., Chen J., Chan S., Chau M. I., Yu H. J., Bahri S., Tseng T., Nalcioglu O., Su M., Development of a quantitative method for analysis of breast density based on three-dimensional breast MRI. Medical Physics 2008 35 12 5253 5262 2-s2.0-56749179848 10.1118/1.3002306
65. Byng J. W., Boydt N. F., Fishell E., Jong R. A., Yaffe M. J., The quantitative analysis of mammographic densities. Physics in Medicine and Biology 1994 39 10 1629 1638 2-s2.0-0028129475 10.1088/0031-9155/39/10/008 (Pubitemid 24306719)
66. Boyd N. F., Greenberg C., Lockwood G., Little L., Martin L., Byng J., Yaffe M., Tritchler D., Effects at two years of a low-fat, high-carbohydrate diet on radiologic features of the breast: results from a randomized trial. Journal of the National Cancer Institute 1997 89 7 488 496 2-s2.0-0030900378 (Pubitemid 27147265)
67. Stone J., Gunasekara A., Martin L. J., Yaffe M., Minkin S., Boyd N. F., The detection of change in mammographic density. Cancer Epidemiology Biomarkers and Prevention 2003 12 7 625 630 2-s2.0-0041345948 (Pubitemid 36899842)
68. Harvey J. A., Bovbjerg V. E., Quantitative assessment of mammographic breast density: relationship with breast cancer risk. Radiology 2004 230 1 29 41 2-s2.0-0346218106 10.1148/radiol.2301020870 (Pubitemid 37549780)
69. Kopans D. B., Basic physics and doubts about relationship between mammographically determined tissue density and breast cancer risk. Radiology 2008 246 2 348 353 2-s2.0-39549083444 10.1148/radiol.2461070309
70. Warren R., Thompson D., del Frate C., Cordell M., Highnam R., Tromans C., Warsi I., Ding J., Sala E., Estrella F., Solomonides A. E., Odeh M., McClatchey R., Bazzocchi M., Amendolia S. R., Brady M., A comparison of some anthropometric parameters between an Italian and a UK population: "proof of principle" of a European project using MammoGrid. Clinical Radiology 2007 62 11 1052 1060 2-s2.0-34848852694 10.1016/j.crad.2007.04.002 (Pubitemid 47500658)
71. Duffy S. W., Nagtegaal I. D., Astley S. M., Gillan M. G. C., McGee M. A., Boggis C. R. M., Wilson M., Beetles U. M., Griffiths M. A., Jain A. K., Johnson J., Roberts R., Deans H., Duncan K. A., Iyengar G., Griffiths P. M., Warwick J., Cuzick J., Gilbert F. J., Visually assessed breast density, breast cancer risk and the importance of the craniocaudal view. Breast Cancer Research 2008 10 4 R64 2-s2.0-65849405860 10.1186/bcr2123
72. Kelemen L. E., Pankratz V. S., Sellers T. A., Brandt K. R., Wang A., Janney C., Fredericksen Z. S., Cerhan J. R., Vachon C. M., Age-specific trends in mammographic density: the Minnesota breast cancer family study. American Journal of Epidemiology 2008 167 9 1027 1036 2-s2.0-42649086025 10.1093/aje/kwn063 (Pubitemid 351601250)
73. Boyd N., Martin L., Stone J., Little L., Minkin S., Yaffe M., A longitudinal study of the effects of menopause on mammographic features. Cancer Epidemiology Biomarkers and Prevention 2002 11 10 1048 1053 2-s2.0-0036801956 (Pubitemid 35192656)
74. Stomper P. C., D'Souza D. J., DiNitto P. A., Arredondo M. A., Analysis of parenchymal density on mammograms in 1353 women 25-79 years old. American Journal of Roentgenology 1996 167 5 1261 1265 2-s2.0-0029907522 (Pubitemid 26376247)
75. Demark-Wahnefried W., Rimer B. K., Winer E. P., Weight gain in women diagnosed with breast cancer. Journal of the American Dietetic Association 1997 97 5 519 526 2-s2.0-0030989125 (Pubitemid 27194773)
76. Lovejoy J. C., The menopause and obesity. Primary Care 2003 30 2 317 325 2-s2.0-0038729647 (Pubitemid 36791420)
77. Paech K., Webb P., Kuiper G. G. J. M., Nilsson S., Gustafsson J., Kushner P. J., Scanlan T. S., Differential ligand activation of estrogen receptors ER α and ERr β at AP1 sites. Science 1997 277 5331 1508 1510 2-s2.0-0030801841 10.1126/science.277.5331.1508 (Pubitemid 27449239)
78. Barkhem T., Carlsson B., Nilsson Y., Enmark E., Gustafsson J., Nilsson S., Differential response of estrogen receptor α and estrogen receptor β to partial estrogen agonists/antagonists. Molecular Pharmacology 1998 54 1 105 112 2-s2.0-0031816540 (Pubitemid 28337592)
79. Cazzaniga M., Bonanni B., Breast cancer chemoprevention: old and new approaches. Journal of Biomedicine and Biotechnology 2012 2012 15 985620 10.1155/2012/985620
80. Li T., Sun L., Miller N., Nicklee T., Woo J., Hulse-Smith L., Tsao M., Khokha R., Martin L., Boyd N., The association of measured breast tissue characteristics with mammographic density and other risk factors for breast cancer. Cancer Epidemiology Biomarkers and Prevention 2005 14 2 343 349 2-s2.0-20944437572 10.1158/1055-9965.EPI-04-0490 (Pubitemid 40270095)
81. Guo Y. P., Martin L. J., Hanna W., Banerjee D., Miller N., Fishell E., Khokha R., Boyd N. F., Growth factors and stromal matrix proteins associated with mammographic densities. Cancer Epidemiology Biomarkers and Prevention 2001 10 3 243 248 2-s2.0-0035730924 (Pubitemid 34288536)
82. Byrne C., Colditz G. A., Willet W. C., Speizer F. E., Pollak M., Hankinson S. E., Plasma insulin-like growth factor (IGF) I, IGF-binding protein 3, and mammographic density. Cancer Research 2000 60 14 3744 3748 2-s2.0-0034660884 (Pubitemid 32204562)
83. Vachon C. M., Sasano H., Ghosh K., Brandt K. R., Watson D. A., Reynolds C., Lingle W. L., Goss P. E., Li R., Aiyar S. E., Scott C. G., Pankratz V. S., Santen R. J., Ingle J. N., Aromatase immunoreactivity is increased in mammographically dense regions of the breast. Breast Cancer Research and Treatment 2011 125 1 243 252 2-s2.0-78651096592 10.1007/s10549-010-0944-6
84. Duschek E. J., de Valk-de Roo G. W., Gooren L. J., Netelenbos C., Effects of conjugated equine estrogen vs. raloxifene on serum insulin-like growth factor-I and insulin-like growth factor binding protein-3: a 2-year, double-blind, placebo-controlled study. Fertility and Sterility 2004 82 2 384 390 2-s2.0-4143062444 10.1016/j.fertnstert.2004.01.033 (Pubitemid 39092039)
85. Colletti R. B., Roberts J. D., Devlin J. T., Copeland K. C., Effect of tamoxifen on plasma insulin-like growth factor I in patients with breast cancer. Cancer Research 1989 49 7 1882 1884 2-s2.0-0024539364 (Pubitemid 19108421)
86. Pollak M., Costantino J., Polychronakos C., Blauer S.-A., Guyda H., Redmond C., Fisher B., Margolese R., Effect of tamoxifen on serum insulinlike growth fator I levels in stage I breast cancer patients. Journal of the National Cancer Institute 1990 82 21 1693 1697 2-s2.0-0025611672
87. Hattar R., Maller O., McDaniel S., Hansen K. C., Hedman K. J., Lyons T. R., Lucia S., Wilson R. S. Jr., Schedin P., Tamoxifen induces pleiotrophic changes in mammary stroma resulting in extracellular matrix that suppresses transformed phenotypes. Breast Cancer Research 2009 11 1 R5 2-s2.0-67549125239 10.1186/bcr2220
88. Higgins M. J., Stearns V., Pharmacogenetics of endocrine therapy for breast cancer. Annual Review of Medicine 2011 62 281 293 2-s2.0-79551604866 10.1146/annurev-med-070909-182545
89. Haiman C. A., Hankinson S. E., De Vivo I., Guillemette C., Ishibe N., Hunter D. J., Byrne C., Polymorphisms in steroid hormone pathway genes and mammographic density. Breast Cancer Research and Treatment 2003 77 1 27 36 2-s2.0-0037267009 10.1023/A:1021112121782 (Pubitemid 36182914)